SAiGENCI is an independent cancer-focused medical research institute located in South Australia; focussing on cancer research and clinical trials, which will include new cutting-edge technologies in immunotherapies and genomics.

Recruitment of Director

Active recruitment of a high-calibre, long-term Director and CEO is underway. The Director will be a highly respected and talented cancer researcher and will, with the support and guidance of the Advisory Board, develop the strategic objectives for SAiGENCI.

Find out more

Research impact

Better breast cancer treatment

Great progress has been made on breast cancer in recent decades. Five-year survival rates in Australia are up to 91%, while 83% survive beyond 10 years. Yet the disease still claims thousands annually and treatment often leaves those who do survive with significantly impaired quality of life.

Find out more

Potential for prostate cancer breakthrough

A new angle on prostate cancer research aims to find better ways to treat the most commonly diagnosed cancer among Australian men.

Find out more

Curbing chemo

Being diagnosed with cancer, one of the world’s most enduring and undiscriminating killers, is distressing enough. But making it a doubly cruel blow is the fact that undergoing one of its most effective treatments, chemotherapy, can itself be utterly debilitating, and even life threatening.

Find out more